NKGN NKGen Biotech, Inc.

2d ago, source: Seeking Alpha

NKGen Biotech, Inc. operates as a clinical-stage biotechnology company that focuses on the development and commercialization of autologous, allogeneic, and CAR-NK natural killer cell therapies.

NKGen Biotech, Inc. (NKGNW)

12d ago, source: Yahoo Finance

SANTA ANA, Calif., Aug. 22, 2024 (GLOBE NEWSWIRE) -- NKGen Biotech, Inc. (Nasdaq: NKGN) (“NKGen” or the “Company”), today announced it received a standard ...

NKGen Biotech to Present at the H.C. Wainwright 26th Annual Global Investment Conference

4d ago, source:

NKGen is a clinical-stage biotechnology company focused on the development and commercialization of innovative autologous, allogeneic, and CAR-NK NK cell therapeutics. NKGen is headquartered in Santa ...

NKGen Biotech Receives Notification From Nasdaq Related to Delayed Quarterly Report

16d ago, source: Yahoo Finance

SANTA ANA, Calif., Aug. 22, 2024 (GLOBE NEWSWIRE) -- NKGen Biotech, Inc. (Nasdaq: NKGN) (“NKGen” or the “Company”), today announced it received a standard notice (the “Notice”) on ...

NKGen Biotech Presents New Positive SNK01 Biomarker Data at the 2024 Alzheimer’s Association International Conference

1mon ago, source: Business Insider

July 30, 2024 (GLOBE NEWSWIRE) -- NKGen Biotech, Inc. (Nasdaq: NKGN) (“NKGen” or the “Company”), a clinical-stage biotechnology company focused on the development and commercialization of ...

NKGen Biotech Inc (NKGN)

3d ago, source: Investing

On March 14, 2024, Sangwoo Park notified the board of directors (the “Board”) of his intention to step down as chairperson of the Board of NKGen Biotech (NKGN). Mr. Park will ...

NKGen Biotech Inc. Wt

24d ago, source: Wall Street Journal

The Price to Earnings (P/E) ratio, a key valuation measure, is calculated by dividing the stock's most recent closing price by the sum of the diluted earnings per share from continuing operations ...

NKGen Biotech Inc (NKGN)

29d ago, source: Investing

In a recent shift of its financial oversight, NKGen Biotech, Inc., a Delaware-based biotech firm, has changed its certifying accountant. On Monday, the company engaged ...

NKGen Biotech Inc NKGN

26d ago, source: Morningstar

We sell different types of products and services to both investment professionals and individual investors. These products and services are usually sold through license agreements or subscriptions ...